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Abstract
Introduction: Bacteria of the genus Proteus are opportunistic pathogens and cause mainly urinary tract infections. They also
play a role in the pathogenesis of reactive arthritis (RA). Patients suffering from Yersinia-triggered RA often carry high titers
of antibodies specific to enterobacterial common antigen (ECA). The immunogenicity of ECA has not received much atten-
tion thus far and studies have focused mainly on the ECA of Escherichia coli and Yersinia enterocolitica. In this paper the
ECA-immunogenicity of Proteus mirabilis is elucidated using two wild-type strains (S1959 and O28) as well as their rough
(R) derivative strains R110/1959, which expresses lipopolysaccharide (LPS) with a full core, and R4/O28, which expresses
LPS with only an inner core.
Materials and Methods: Rabbit polyclonal antisera were produced by immunization with boiled suspensions of the four P.
mirabilis strains. The antisera were tested for the presence of antibodies specific to ECA by Western blotting using glyc-
erophospholipid-linked ECA (ECAPG) of Salmonella montevideo as antigen. Lipopolysaccharide (LPS) was isolated from the
four strains by the hot phenol/water procedure in which ECAPG is co-extracted with LPS and by the
phenol/chloroform/petroleum ether extraction that results in the isolation of LPS and/or LPS-linked ECA (ECALPS) free of
ECAPG. The LPS preparations were tested for the presence of ECA by Western blotting using ECA-specific antibodies.
Results: The results demonstrated that all four P. mirabilis strains were ECA immunogenic. The rabbit antisera immunized
by the four strains all contained ECA-specific antibodies. Analysis of the LPS preparations demonstrated that the P. mirabilis
wild-type strains O28 and S1959 and the Ra mutant strain R110/1959 expressed ECALPS, suggesting that it induced the anti-
ECA antibody responses. Only the presence of ECAPG could be demonstrated in the Rc mutant strain R4/O28. 
Conclusions: These results therefore suggest that, similar to E. coli, LPS with a full core is also required as the acceptor of
ECA for P. mirabilis strains to produce ECALPS. Since ECAPG is not immunogenic unless combined with some proteins, it is
likely that ECAPG-protein complexes formed during the intravenous immunization with the Rc mutant strain R4/O28.
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INTRODUCTION
The genus Proteus contains five named species:
P. mirabilis, P. penneri, P. vulgaris, P. myxofaciens, and
P. hauseri, and three unnamed genomospecies 4, 5, and 6
(O’Hara et al. 2000a; O’Hara et al. 2000b; Ró¿alski
2002). These Gram-negative rods are widespread in the
environment, for example in soil, water, and sewage,
and, with the exception of P. myxofaciens, are common
human intestinal and urinary tract pathogens (Ró¿alski
et al. 1997). Under favorable conditions, Proteus infec-
tions may lead to serious complications, such as acute or
chronic pyelonephritis, the formation of bladder and
kidney stones, and catheter obstruction (Ró¿alski 2002).
Evidence was recently presented that P. mirabilis is an
etiopathogenic agent in rheumatoid arthritis, a chronic
inflammatory polyarthritic disease (Rashid and Ebrin-
ger 2007). 
Several virulence factors have been identified in
Proteus strains. The most important are fimbriae-medi-
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ated adherence, glycocalyx formation, lipopolysaccha-
ride (LPS), and probably also enterobacterial common
antigen (ECA). Interestingly, antibodies against ECA
are present in the serum of patients suffering from reac-
tive arthritis (Granfors et al. 1989; Rastawicki 2007). 
ECA, a cell surface lipoglycan, is present in all bacte-
ria of the family Enterobacteriaceae, with the exception of
the plant pathogenic bacterium Erwinia chrysanthemi
(Kuhn et al. 1987; Rinno et al. 1980). ECA is a het-
eropolymer built of →3)-α-D-Fucp4NAc-(1→4)-β-D-
-ManpNAcA-(1→4)-α-D-GlcpNAc-(1→ trisaccharide
repeating units (£ugowski et al. 1983). It occurs in three
structurally different forms: (i) ECAPG, which is
anchored in the outer membrane of the bacterial cell
wall via L-glycerophospholipid, (ii) ECALPS, in which
lipid A functions as a membrane-anchor and to which
ECA is linked via the core oligosaccharide, and (iii)
ECACYC, which is deprived of a lipid carrier and is locat-
ed in the periplasm (Kajimura et al. 2005; Kuhn et al.
1988). The ECAPG form is not immunogenic unless
bound to a protein, which could occur in animal serum
after intravenous injection. ECALPS, in contrast, is
immunogenic. Presence of ECALPS has been demon-
strated in E. coli Ra mutants possessing the full core type
of coli R1, R4, and K-12 in their LPS (Kuhn et al. 1988)
and also in E. coli Ra mutants with the full core type of
coli R2 or R3 (Kasperkiewicz et al. 2004). We have also
shown that Yersinia enterocolitica O:3 R mutants with
a full core (chemotype Ra) as well as those with a trun-
cated outer core or only an inner core (chemotype Rc) in
their LPS are ECA immunogenic. In all of them, ECA
was linked to the inner core of the LPS (Duda 2007a;
Duda 2007b; Radziejewska-Lebrecht et al. 2003).
Moreover, the Y. enterocolitica O:3 wild-type strain
Ye75S was ECA immunogenic in rabbits and contained
O-chain polysaccharide as well as ECA bound to the
inner core of its LPS (Radziejewska-Lebrecht et al.
1998). In this study we wanted to examine whether




P. mirabilis strains O28 (wild type), S1959 (wild type),
R4/O28 (rough, Rc chemotype), and R110/1959 (rough,
Ra chemotype), described earlier (Radziejewska-Le-
brecht et al. 1980; Radziejewska-Lebrecht and Mayer
1989; Vinogradov and Radziejewska-Lebrecht 2000;
Vinogradov et al. 2000), were obtained from the collection
of the Institute of Microbiology and Immunology in £ódŸ.
Antigens and serological assays
LPS preparations (LPS Ph/W) of P. mirabilis O28
(Vinogradov and Radziejewska-Lebrecht 2000) and
S1959 (Vinogradov et al. 2000) were obtained by the hot
phenol/water procedure of Westphal (Westphal and
Jann 1965). LPS Ph/W was then subjected to the phe-
nol/chloroform/light petroleum (PCP) procedure of
Galanos (Galanos et al. 1969) to obtain LPS PCP. Only
the LPS PCP preparation was obtained from the Ra
mutant strain R110/1959 by straight PCP extraction of
the dry bacterial mass (Radziejewska-Lebrecht and
Mayer 1989). For the Rc mutant strain R4/O28, both
the LPS Ph/W and LPS PCP preparations were acquired
directly from dry bacterial mass (Radziejewska-Le-
brecht et al. 1980; Radziejewska-Lebrecht et al. 1988).
The LPS Ph/W preparations may contain ECAPG, which
co-extracts with LPS in the hot phenol/water procedure,
whereas LPS PCP preparations are deprived of ECAPG
and contain LPS and, if present, also ECALPS. The LPS
preparations and the control ECAPG preparation from
S. montevideo SH94 (kind gift from Drs. H. Mayer and
H.-M. Kuhn, Max-Planck-Institute, Freiburg, Germany)
were used as antigens in SDS/polyacrylamide gel elec-
trophoresis (SDS/PAGE) and Western blotting as
described (Radziejewska-Lebrecht et al. 2003). The
experiments were repeated five times and representa-
tive results are shown in the figures. 
Antibodies and antisera
Monoclonal antibody specific to ECA, mAb 898,
recognizing the ManpNAcA epitope (Meier-Dieter et
al. 1989) was a kind gift from Prof. D. Bitter-Suermann
(Institute of Medical Microbiology, Hannover,
Germany). 
The monovalent antiserum against the ECA of
E. coli O14:K7 was prepared by the adsorption of rabbit
antiserum against E. coli O14:K7 by isogenic ECA-neg-
ative mutant bacteria. The antiserum, enriched in anti-
-ECA antibodies, was received from Dr. H. Mayer from
the Max-Planck-Institute, Freiburg, Germany (Männel
and Mayer 1978). Alkaline phosphatase-conjugated
goat anti-mouse and goat anti-rabbit immunoglobulin
antibodies (D0486 and D0487, respectively, DAKO)
were used in a 1:2000 dilution as the secondary antibod-
ies in Western blotting.
Polyclonal antisera against P. mirabilis strains O28,
S1959, and R110/1959 as well as antiserum against
Staphylococcus albus(used as anegative control as it lacks
cross-reactivity with LPS and ECA, which are typical anti-
gens of Gram-negative bacteria) were obtained by immu-
nization of New Zealand white rabbits with heat-killed
bacterial suspensions. Immunization was carried out with
the bacterial suspensions (1.5 × 1010 CFU/ml) at doses of
0.25, 0.5, and 1 ml of each over a period of 10 days. The
antisera obtained seven days after the last injection were
stored at –20°C. Polyclonal antiserum against P. mirabilis
strain R4/O28 was obtained by immunization of New
Zealand white rabbits with 500-µl doses containing 50, 75,
100, 150, 200, and 500 µg of lyophilized heat-killed bacte-
rial mass in sterile 0.85% NaCl over a period of 51 days.
The antiserum obtained seven days after the last injection
was stored at –20°C.K. A. Duda et al.: ECA-immunogenicity of Proteus  149
RESULTS AND DISCUSSION
In the present study, two smooth (serogroup O:28
and O:3) and two rough P. mirabilis strains were tested
for their ECA-immunogenicity. The results (Fig. 1,
panel A) demonstrate that ECA-specific antibodies
were present in all the tested antisera. The ladder-like
banding profile characteristic of ECA was present in the
10- to 50-kDa region, similar to that in the control reac-
tion with ECA-specific mAb 898 (Fig. 1, panel B). The
antisera against the Rc mutant R4/O28 and the Ra
mutant R110/1959 (the ladder-like profile for this sam-
ple is only faintly visible) contained higher titers of anti-
-ECA antibodies than the antisera against the wild-type
strains O28 and S1959. Although there is a possibility of
variation among individual rabbits, it is likely that the
differences in titers are due to small amounts of
immunogenic ECA in the latter bacteria (see below) or
to the possibility that in the wild-type strains the ECA
chains could be masked by the abundant O-polysaccha-
rides chains on the bacterial cell wall. However, the lat-
ter alternative might not be valid as the bacteria are
most likely degraded and processed by rabbit antigen-
presenting cells during immunization. Acker et al.
reported that on whole bacteria, ECA is better exposed
on the cell surface of Rc mutant Ye75R bacteria than on
the parental S strain Ye75S bacteria (Acker et al. 1981).
ECA-immunogenicity was previously demonstrated
for  E. coli and  Y. enterocolitica O:3 strains (Duda
2007b; Kuhn et al. 1988; Radziejewska-Lebrecht et al.
1998; Radziejewska-Lebrecht et al. 2003). We showed
above that all the tested P. mirabilis strains were also
ECA immunogenic and that this was independent of
the core structure, similarly to the Yersinia  strains.
Subsequently, we wanted to elucidate whether the
observed ECA-immunogenicity was due to ECALPS or
ECAPG. In the immunoblot analysis developed with
ECA-specific mAb 898 (Fig. 2, panel A), all the LPS
Ph/W preparations from the P. mirabilis strains O28,
R4/O28, and S1959 reacted positively in the high-mole-
cular-mass region, indicating the presence of ECA
(ECAPG and/or ECALPS), similarly to the control reac-
tion with ECAPG. The strongest reaction was observed
for the LPS Ph/W of the Rc mutant R4/O28 and the
weakest for the LPSs of S1959 and R110/1959 (Fig. 2,
panel A). A weak reaction could be detected on the
membrane, but it is not visible in the scanned picture;
the locations of the stained bands are indicated by
braces. In the case of the LPS PCP preparation of the
Rc mutant R4/O28, no reaction with mAb 898 was
observed; however, it was present in the LPS PCP of
the parental strain O28. The gel was silver-stained after
transfer of the samples to the nitrocellulose membrane
(Fig. 2, panel B) and this confirmed the proper loading
of the samples onto the gel. At the same time it indi-
cated that the lack of reactivity of the R4/O28 LPS PCP
with mAb 898 was likely due to the absence of ECALPS
in this preparation. Of note, ECA preparations cannot
be silver-stained as there are no vicinal hydroxyl groups
in the ECA repeat unit required for the oxidation step
in the staining; thus it is not visible in Fig. 2, panel B. 
In conclusion, the obtained results suggest that the
ECA-immunogenicity of the smooth strains O28 and
S1959 and of the Ra mutant R110/1959 was due to the
presence of ECALPS, whereas that of the Rc mutant
R4/O28 was due to the presence of ECAPG. As men-
tioned, the latter co-extracts with LPS in the Ph/W pro-
cedure.
Our previous studies on R mutants of Y. enterocoliti-
ca O:3 showed that monovalent antiserum against E. coli
O14:K7 enriched with ECA-specific antibodies was
a more sensitive tool in the detection of ECA than mAb
898, perhaps reflecting a lower affinity of the mono-
clonal antibody (Duda 2007a). In line with this, the
immunostainings with the monovalent antiserum (Fig.
3, panel A) were stronger than with mAb 898 (Fig. 2,
panel A). All the P. mirabilis LPS preparations gave pos-
itive reactions in the 10- to 50-kDa region correspond-
ing to ECA compared with the control reaction with
ECAPG (Fig. 3, panel A), with the exception of the LPS
PCP of R4/O28. As above, the gel was silver-stained
after transfer of the samples to the nitrocellulose mem-
brane (Fig. 3, panel B) and this confirmed the proper
loading of the samples onto the gel, including that of the
R4/O28 LPS PCP. As mentioned above, the ECA-
-immunogenicity of this Rc mutant was most likely due
to ECAPG. ECAPG has been reported to be a very poor
immunogen; however, its immunogenicity would
increase if it were covalently bound or associated with
Fig. 1. P. mirabilis-immunized rabbit sera contain ECA-specific
antibodies detected by Western blotting. The ECAPG of S. monte-
video (2 µg per lane) was used as the antigen. Panel A. Antisera
from rabbits immunized with P. mirabilis strains O28, R4/O28,
S1959, and R110/1959. Panel B. ECA-specific monoclonal antibo-
dy mAb 898 (positive control). Panel C. Antiserum from rabbit im-
munized with Staphylococcus albus (negative control). The dilu-
tions of the antisera at which the reactions were carried out are in-
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a carrier, for example proteins (Kuhn et al. 1988), and
this is the likely explanation for the ECA immunogenic-
ity of the Rc mutant R4/O28.
The expression of ECALPS by the Ra mutant
R110/1959 with a full core region and not by the Rc
mutant R4/O28 with a truncated core region suggests
that in P. mirabilis, similarly to E. coli, the complete core
region of LPS is a prerequisite for the linking of ECA to
LPS. This conclusion is additionally supported by the
following two observations. (i) The presence in the 1- to
5-kDa region of the membrane of the two clearly sepa-
rated ECA-positive bands in the LPS PCP preparation
of strain O28 and several similar bands in the LPS PCP
of the Ra mutant R110/1959; these bands correspond to
the migration of full core molecules (Fig. 3, panel A).
(ii) The lack of ECA-specific immunostaining in the 1-
to 5-kDa region of the LPS PCP preparation of the Rc
mutant R4/O28, which possesses only the inner core in
its LPS.
In contrast to previous observations (Kuhn et al.
1988), it is very likely that ECALPS occurs abundantly in
nature and one can envision that in wild-type strains
Fig. 2. Detection of ECA in the LPS preparations of P. mirabilis strains. Panel A. Western blotting using ECA-specific mAb 898 at a 1:200
dilution. Panel B. Silver-stained gel after transfer of the samples to the PVDF membrane. The LPS Ph/W and LPS PCP preparations (15 µg
per lane) of P. mirabilis strains O28, R4/O28, S1959, and R110/1959 and ECAPG of S. montevideo (positive control, 2 µg per lane) were ana-
lyzed as indicated below the images.
Fig. 3. Detection of ECA in the LPS preparations of P. mirabilis strains. Panel A. Western blotting using 1:200 diluted monospecific anti-
-E. coli O14:K7 antiserum enriched in ECA-specific antibodies. Panel B. Silver-stained gel after transfer of the samples to the PVDF mem-
brane. The LPS Ph/W and LPS PCP preparations (15 µg per lane) of P. mirabilis strains O28, R4/O28, S1959, and R110/1959 and ECAPG
of S. montevideo (positive control, 2 µg per lane) were analyzed as indicated below the images.K. A. Duda et al.: ECA-immunogenicity of Proteus  151
under certain environmental conditions, a higher pro-
portion of LPS molecules could be unsubstituted by O-
-polysaccharide and they could then become ECA-sub-
stituted. Our results therefore warrant further studies to
find out whether other members of Enterobacteriaceae
in addition to E. coli, Y. enterocolitica, and P. mirabilis
express ECA-immunogenic ECALPS.
Acknowledgment:  We wish to thank Prof. Antoni Ró¿alski
(£ódŸ, Poland) for the gift of rabbit anti-Proteus antisera.
REFERENCES
Acker G, Knapp W, Wartenberg K et al (1981) Localization of
enterobacterial common antigen in Yersinia enterocolitica by
the immunoferritin technique. J Bacteriol 147:602–611
Duda KA (2007a) Immunochemical studies on lipopolysaccha-
rides from R mutants Yersinia enterocolitica O:3. Ph D Thesis.
University of Silesia, Katowice, Poland and Research Center
Borstel, Borstel, Germany
Duda KT (2007b) Reactivity of polyclonal antisera against
R mutants of Yersinia enterocolitica O:3. Ph D Thesis.
University of Silesia, Katowice, Poland and The Haartman
Institute, University of Helsinki, Helsinki, Finland
Galanos C, Lüderitz O, Westphal O (1969) A new method for
the extraction of R lipopolysaccharides. Eur J Biochem
9:245–249
Granfors K, Jalkanen S, von Essen R et al (1989) Yersinia anti-
gens in synovial-fluid cells from patients with reactive arthritis.
N Engl J Med 320:216–221
Kajimura J, Rahman A, Rick PD (2005) Assembly of cyclic
enterobacterial common antigen in Escherichia coli K-12.
J Bacteriol 187:6917–6927
Kasperkiewicz K, Skurnik M, Brade L et al (2004) Monoclonal
antibodies specific for lipid A and ECA as tools in characteri-
zation of lipopolysaccharides from enterobacterial R mutants.
3rd German-Polish-Russian Meeting on Bacterial
Carbohydrates, October 6–9, Wroc³aw, Poland. Abstract P10
Kuhn HM, Basu S, Mayer H (1987) Comparison of enterobac-
terial common antigen from different species by serological
techniques. Eur J Biochem 162:69–74
Kuhn HM, Meier-Dieter U, Mayer H (1988) ECA, the enter-
obacterial common antigen. FEMS Microbiol Rev 4:195–222
£ugowski C, Romanowska E, Kenne L et al (1983)
Identification of trisaccharide repeating unit in the enterobac-
terial common antigen. Carbohydr Res 118:173–181
Männel D, Mayer H (1978) Isolation and chemical characteri-
zation of the enterobacterial common antigen. Eur J Biochem
86:361–370
Meier-Dieter U, Acker G, Mayer H (1989) Detection of enter-
obacterial common antigen on bacterial cell surfaces by
colony-immunoblotting: effect of its linkage to lipopolysaccha-
ride. FEMS Microbiol Lett 50:215–220
O’Hara CM, Brenner FW, Miller JM (2000a) Classification,
identification, and clinical significance of Proteus, Providencia,
and Morganella. Clin Microbiol Rev 13:534–546
O’Hara CM, Brenner FW, Streigerwalt AG (2000b)
Classification of Proteus vulgaris biogroup 3 with recognition of
Proteus hauserii sp. nov. nom. rev. and unnamed Proteus
genomospecies 4, 5 and 6. Int J Syst Evol Microbiol
50:1869–1875
Radziejewska-Lebrecht J, Bhat UR, Brade H et al (1988)
Structural studies on the core and lipid A region of a 4-amino-
-L-arabinose-lacking Rc-type mutant of Proteus mirabilis. Eur
J Biochem 172:535–541
Radziejewska-Lebrecht J, Feige U, Jensen M et al (1980)
Structural studies on the glucose-heptose region of the Proteus
mirabilis R core. Eur J Biochem 107:31–38
Radziejewska-Lebrecht J, Kasperkiewicz K, Skurnik M et al
(2003) ECA-antibodies in antisera against R mutants of
Yersinia enterocolitica O:3. Adv Exp Med Biol 529:215–218
Radziejewska-Lebrecht J, Mayer H (1989) The core region of
Proteus mirabilis R110/1959 lipopolysaccharide. Eur J Biochem
183:573–581
Radziejewska-Lebrecht J, Skurnik M, Shashkov AS et al
(1998) Immunochemical studies on R mutants of Yersinia ente-
rocolitica O:3. Acta Biochim Pol 45:1011–1019
Rashid T, Ebringer A (2007) Rheumatoid arthritis is linked to
Proteus – the evidence. Clin Rheumatol 26:036–1043
Rastawicki W (2007) Humoral response to selected antigens of
Yersinia enterocolitica and  Yersinia pseudotuberculosis in the
course of yersiniosis in humans. I. Occurrence of antibodies to
enterobacterial common antigen (ECA). Med Dosw Microbiol
59:93–102 
Rinno I, Golecki JR, Mayer H (1980) Localization of enter-
obacterial common antigen: Immunogenic and nonimmuno-
genic entrobacterial common antigen-containing Escherichia
coli. J Bacteriol 141:814–821
Ró¿alski A (2002) Molecular basis of the pathogenicity of
Proteus bacteria. Adv Clin Exp Med 11:3–18
Ró¿alski A, Sidorczyk Z, Kote³ko K (1997) Potential virulence
factors of Proteus bacilli. Microbiol Mol Biol Rev 61:65–89.
Vinogradov E, Radziejewska-Lebrecht J (2000) The structure
of the carbohydrate backbone of the core-lipid A region of the
lipopolysaccharide from Proteus mirabilis serotype O28.
Carbohydr Res 329:351–357
Vinogradov E, Radziejewska-Lebrecht J, Kaca W (2000) The
structure of the carbohydrate backbone of core-lipid A region
of the lipopolysaccharides from Proteus mirabilis wild-type
strain S1959 (serotype O3) and its Ra mutant R110/1959. Eur
J Biochem 267:262–269
Westphal O, Jann K (1965) Bacterial lipopolysaccharide
extraction with phenol-water and further application of proce-
dure. Met Carbohydr Chem 5:83–91